Aging
Navigate
Back to articleFigure 3(3 of 3)
100%
Figure 3
Figure 3.bRFS outcome in patients treated with hypofractionated IG-VMAT versus conventionally fractionated IG-VMAT. bRFS, biochemical relapse–free survival; IG, imaging-guided; volumetric-modulated arc therapy, VMAT.
Figure 3 — Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China | Aging